| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.76B | 1.31B | 1.42B | 737.08M | 496.99M |
| Gross Profit | 539.34M | 612.29M | 660.09M | 376.94M | 151.29M |
| EBITDA | 1.11B | 746.92M | 909.19M | 411.45M | 198.89M |
| Net Income | -262.99M | 188.07M | 184.94M | 17.27M | -96.05M |
Balance Sheet | |||||
| Total Assets | 5.59B | 5.92B | 5.78B | 5.73B | 5.24B |
| Cash, Cash Equivalents and Short-Term Investments | 326.73M | 182.25M | 365.95M | 442.97M | 747.98M |
| Total Debt | 3.63B | 3.28B | 3.29B | 3.05B | 2.99B |
| Total Liabilities | 5.45B | 5.29B | 5.10B | 5.08B | 4.52B |
| Stockholders Equity | 141.67M | 638.09M | 686.12M | 650.20M | 717.12M |
Cash Flow | |||||
| Free Cash Flow | 170.77M | 356.43M | 115.12M | -123.60M | -271.00M |
| Operating Cash Flow | 937.52M | 1.12B | 656.19M | 272.15M | 132.50M |
| Investing Cash Flow | -976.34M | -809.42M | -416.46M | -307.94M | -642.78M |
| Financing Cash Flow | 18.48M | -426.04M | -327.35M | -267.48M | 1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £3.57B | 28.81 | 9.72% | 5.64% | 49.70% | -5.56% | |
70 Outperform | £4.24B | 21.34 | 9.33% | 14.05% | 36.10% | ― | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | £1.07B | -19.56 | -7.42% | 9.30% | -20.00% | -154.63% | |
58 Neutral | £1.59B | -1.49 | -65.81% | 10.99% | 27.35% | -228.25% | |
53 Neutral | £679.58M | -2.65 | -19.93% | ― | ― | ― | |
50 Neutral | £140.42M | -5.79 | -11.54% | ― | -10.76% | 88.89% |